Memo Therapeutics
Series BMemo Therapeutics raised €35M in a Series B round in Feb 2022. The company is based in Zurich, Switzerland. Investors in the round: Adjuvant Capital, Fresenius Medical Care Ventures, GF Group Holding and 4 others. Data as of 4 Nov 2026.
Amount raised
€35M
€35,184,481
Native amount
37,000,000 CHF
Stage
Series B
series b
Investors
7
Provenance & confidence
High confidenceAmount
37,000,000 CHF
ECB-at-date → €35M · rate 1.0516 on 2022-02-16
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 namedAdjuvant CapitalFresenius Medical Care VenturesGF Group HoldingSwisscanto InvestVerve VenturesVesalius Biocapital PartnersZürcher Kantonalbank
Date
Feb 2022
Round type
series b
Amount (EUR)
€35M
Other rounds
same companyRelated news
- Memo Therapeutics Raises CHF23M Extension; Closes CHF37M Series B Financingfinsmes.com · 2022-02